In a complex TME, the survival, proliferation, and activation of CAR T cells are affected by a variety of immunosuppressive cells and factors [31], among which TGF-β is a key regulator in reshaping TME due to vast roles in tumour mediated immune suppression. The gene discussed is TGFB1; the disease is neoplasm.